Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Jul-Aug;18(4):1106-1112.
doi: 10.1016/j.brs.2025.04.023. Epub 2025 May 8.

A randomized controlled trial of anodal transcranial direct current stimulation (A-tDCS) and olfactory training in persistent COVID-19 anosmia

Collaborators, Affiliations
Free article
Randomized Controlled Trial

A randomized controlled trial of anodal transcranial direct current stimulation (A-tDCS) and olfactory training in persistent COVID-19 anosmia

Lucilla Vestito et al. Brain Stimul. 2025 Jul-Aug.
Free article

Abstract

Background: Persistent anosmia due to COVID-19 affects approximately 20 million individuals worldwide, with a serious detrimental effect on their quality of life. Effective treatments remain lacking, with olfactory training (OT) being supported by some evidence of benefit. We implemented a double-blind, randomized, controlled trial (RCT) combining OT with Anodal transcranial Direct Current Stimulation (A-tDCS) with the aim to confirm the encouraging results of a preliminary study by our group. We also evaluated the long-term effectiveness of this intervention at both one- and six-months post-treatment assessments.

Methods: This RCT involved 52 patients with persistent hypo/anosmia due to COVID-19. Participants were randomly assigned to undergo OT coupled with either A-tDCS targeting the Prefrontal Cortex (PFC) (experimental group, n = 35), or sham stimulation (placebo group, n = 17) for two weeks (10 sessions). The end point was the change in smell function from the baseline, as assessed by subjective and objective scores (VAS and Sniffin' Sticks test or SST).

Results: The experimental group demonstrated a significant amelioration of both smell measures. Specifically, the mean VAS-smell increased from 2.56 to 4.70 (p < 0.001) and the mean SST from 6.97 to 9.69 (p < 0.001). Seventy-seven percent of patients in the experimental group significantly improved, with 63 % achieving a complete recovery. No olfactory amelioration was observed in the placebo group. The significant smell improvement was sustained at both follow-up assessments.

Conclusion: This RCT demonstrates that combining A-tDCS with concurrent OT is able to restore the olfactory function in individuals suffering from persistent COVID-19 anosmia, with a durable effect. This safe and inexpensive treatment can therefore represent a suitable and widespread option for millions of individuals. These positive results also support the hypothesis that the brain olfactory networks are involved in the pathophysiology of COVID-19 anosmia.

Keywords: Persistent olfaction disorder-COVID-19 virus infection-anodal stimulation tDCS- olfactory training.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Similar articles

Publication types

LinkOut - more resources